Financials
Financial year 2025
SERB from Elsene, company number BE0538813719, closed financial year 2025 with a result of € 13.7 million after tax. For that financial year SERB recorded revenue of € 96.9 million and equity of € 49.5 million. Compared with financial year 2024, the result moved from € 16.3 million to € 13.7 million. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 8, 2026.
€ 49.5 million
▲ 28% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 13.7 million
▼ 16% vs 2024
Profit after tax over the fiscal year.
€ 10.9 million
▼ 38% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 2.8 million paid out
21 % of the profit went to the shareholders, mostly to STARK INTERNATIONAL LUX SARL (100 % of the shares). That is where the money ends up.
People and assets in 2025
9.7
▼ 0.2 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 2.3 million
▲ 13% vs 2024
€ 235,600 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 30,644
▼ 6% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 62.8 million
Loans from banks and other lenders, long and short.
€ 41.8 million
▲ 2% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 187 days on average.
€ 816,772
▲ 21% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 78,463,774 | € 91,794,900 | € 92,036,839 | € 96,880,725 | ▲ 5% |
| Profit after taxes | € 7,239,703 | € -6,161,212 | € 16,282,065 | € 13,724,738 | ▼ 16% |
| Equity | € 37,642,451 | € 31,481,239 | € 38,663,304 | € 49,543,416 | ▲ 28% |
| Total debts | € 142,101,297 | € 101,099,283 | € 114,902,321 | € 109,716,832 | ▼ 5% |
| Cash | € 42,474,771 | € 14,917,084 | € 17,555,824 | € 10,905,076 | ▼ 38% |
| Retained profit | € 4,544,882 | € -1,616,330 | € 5,565,735 | € 16,445,847 | ▲ 195% |
| Dividend | € 6,877,718 | € 0 | € 9,100,000 | € 2,844,626 | ▼ 69% |
| Bank debt | € 100,145,597 | € 62,826,769 | € 62,826,769 | € 62,826,769 | |
| Balance sheet total | € 179,761,253 | € 132,598,028 | € 153,565,625 | € 159,260,248 | ▲ 4% |
| Employees (FTE) | 9 | 9.6 | 9.9 | 9.7 | ▼ 0.2 |
By revenue, SERB ranks 2nd of 9 companies with main activity “Groothandel in farmaceutische en medische artikelen” in Elsene that publish figures (fiscal year 2025).
Key figures of SERB, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about SERB the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to SERB?
What happened at SERB in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Antoine BERNASCONI stepped down as director. NBB
- Marc BUCHET stepped down as director. NBB
- Bich PHAM HUY stepped down as director. NBB
- Capital increase of € 25.9 million, published in the Gazette. Source: Staatsblad ↗
- New annual accounts for financial year 2025: profit of € 13.7 million (▼ 16% vs 2024). Source: NBB ↗
- Marc BUCHET became a director. NBB
- Antoine BERNASCONI became a director. NBB
- Bich PHAM HUY became a director. NBB
In short
From € 7.2 million profit in 2022 to € 13.7 million profit in 2025.
Paid € 12.7 million in corporate taxes since 2022.
Best year ever: 2024, with € 16.3 million profit.
Paid out € 18.8 million in dividends to the owners in total.
Management
The shares are held by STARK INTERNATIONAL LUX SARL (100%).
Directors
According to the 2025 annual accounts
Antoine BERNASCONI
Director
since 2023 · until 2029
Marc BUCHET
Director
since 2024 · until 2029
Bich PHAM HUY
Director
since 2023 · until 2029
Shareholders
STARK INTERNATIONAL LUX SARL
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Louizalaan 480
1050 Elsene
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Elsene
Same main activity (Groothandel in farmaceutische en medische artikelen), 32 active companies in Elsene, largest first.
€ 164.7 million revenue · 2025
Boehringer Ingelheim Animal Health Belgium SA
€ 50.6 million revenue · 2025
€ 23.5 million revenue · 2025
€ 21.4 million revenue · 2026
€ 16.2 million revenue · 2025
€ 11.1 million revenue · 2025
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Capital increase
Source: Deed ↗- Stark International Lux S.à.r.l(inbrenger (deel van schuldvordering)) 43.9%
Capital increase
Source: Deed ↗- STARK INTERNATIONAL LUX S.à.r.l.(apporteur) 37.7%
Capital increase
Source: Deed ↗- STARK INTERNATIONAL LUX(aandeelhouder) 42.8%
Details
- Company number
- 0538.813.719
- VAT number
- BE 0538.813.719
- Registered office
- Louizalaan 480, 1050 Elsene
- Names & denominations
- SERB
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 20 September 2013
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Vervaardiging van geneesmiddelen